Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HLT | CI |
|---|---|---|
| Price | $312.80 | $266.19 |
| Change today | ▲ 1.81% | ▼ 0.78% |
| Market cap | $70.40B | $70.34B |
| Return, 3 months | -8.9% | -4.2% |
| Return, year to date | +9.0% | -1.6% |
| Return, 1 year | +19.1% | -6.6% |
| P/E (TTM) | 45.9 | 11.0 |
| P/B | -11.2 | 1.7 |
| P/E percentile vs own 5y | 59th | 12th |
| Dividend yield | 0.19% | 2.31% |
| Revenue growth (YoY, latest qtr) | +6.5% | +6.7% |
| Net profit growth (YoY) | +9.0% | +14.9% |
| Gross margin | 29.3% | 8.8% |
| Operating margin | 23.3% | 3.2% |
| Net margin | 12.7% | 2.3% |
| Return on equity | – | 15.5% |
| Analyst target vs. price | +14.5% | +26.9% |
| Analyst buy share | 71% | 69% |
| RSI (14) | 44 | 44 |
| 30-day volatility | 19.6% | 22.0% |
| Max drawdown, 1 year | -13.6% | -21.4% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.